Lauren E Walker Selected Research

COVID-19

11/2022	Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial.
1/2022	An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren E Walker Research Topics

Disease

3	Frailty 03/2024 - 01/2022
2	COVID-19 11/2022 - 01/2022
2	Acute Kidney Injury (Acute Renal Failure) 12/2021 - 01/2019
2	Burns 01/2021 - 01/2018
1	Cognitive Dysfunction 03/2024
1	Heart Failure 03/2024
1	Mental Disorders (Mental Disorder) 01/2024
1	Alcoholism (Alcohol Abuse) 12/2022
1	Diarrhea 01/2022
1	Wounds and Injuries (Trauma) 12/2021
1	Femoral Fractures (Femoral Fracture) 12/2021
1	Osteoporotic Fractures 12/2021
1	Opioid-Related Disorders (Opiate Addiction) 12/2021
1	Hyperkalemia 12/2018
1	Chemical and Drug Induced Liver Injury 05/2018
1	Inflammation (Inflammations) 01/2016
1	Epilepsy (Aura) 01/2016
1	Psychotic Disorders (Schizoaffective Disorder) 05/2011
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2009
1	Neoplasms (Cancer) 01/2009
1	Circulating Neoplastic Cells 01/2009
1	Lung Neoplasms (Lung Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 05/2018 - 01/2009
2	Opioid Analgesics (Opioids)IBA 12/2022 - 12/2021
2	Antiviral Agents (Antivirals)IBA 11/2022 - 01/2022
1	Antipsychotic Agents (Antipsychotics)IBA 01/2024
1	molnupiravirIBA 11/2022
1	BilirubinIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 12/2021
1	PotassiumIBA 12/2018
1	CreatinineIBA 01/2018
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2018
1	Hormones (Hormone)IBA 01/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 05/2011
1	ChromograninsIBA 01/2009
1	Messenger RNA (mRNA)IBA 01/2009
1	RNA (Ribonucleic Acid)IBA 01/2009
1	RE1-silencing transcription factorIBA 01/2009

Therapy/Procedure

3	Polypharmacy 03/2024 - 01/2022
3	Renal Replacement Therapy (Therapies, Renal Replacement) 12/2021 - 12/2018
1	Precision Medicine 03/2024
1	Continuous Renal Replacement Therapy 12/2021
1	Duration of Therapy 12/2021
1	Therapeutics 12/2021
1	Surgical Amputation (Amputations) 01/2021
1	Hemoperfusion 12/2018